158 related articles for article (PubMed ID: 33966296)
1. Diagnostic concordance of phyllodes tumour of the breast.
Rakha E; Mihai R; Abbas A; Bennett R; Campora M; Morena P; Toss M; Ellis I
Histopathology; 2021 Oct; 79(4):607-618. PubMed ID: 33966296
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme.
Rakha EA; Ahmed MA; Aleskandarany MA; Hodi Z; Lee AH; Pinder SE; Ellis IO
Histopathology; 2017 Mar; 70(4):632-642. PubMed ID: 28028831
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
Di Liso E; Bottosso M; Lo Mele M; Tsvetkova V; Dieci MV; Miglietta F; Falci C; Faggioni G; Tasca G; Giorgi CA; Giarratano T; Mioranza E; Michieletto S; Saibene T; Dei Tos AP; Conte P; Guarneri V
ESMO Open; 2020 Oct; 5(5):e000843. PubMed ID: 33020219
[TBL] [Abstract][Full Text] [Related]
4. Audit of fibroepithelial tumors of the breast in a Nigerian tertiary institution.
Daramola AO; Oguntunde OA; Awolola NA
Niger J Clin Pract; 2016; 19(5):645-8. PubMed ID: 27538554
[TBL] [Abstract][Full Text] [Related]
5. Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology.
Dessauvagie BF; Lee AHS; Meehan K; Nijhawan A; Tan PH; Thomas J; Tie B; Treanor D; Umar S; Hanby AM; Millican-Slater R
J Clin Pathol; 2018 Aug; 71(8):672-679. PubMed ID: 29440134
[TBL] [Abstract][Full Text] [Related]
6. Can problematic fibroepithelial lesions be accurately classified on core needle biopsies?
Bandyopadhyay S; Barak S; Hayek K; Thomas S; Saeed H; Beydoun R; Shi D; Arabi H; Ruterbusch J; Cote M; Ali-Fehmi R
Hum Pathol; 2016 Jan; 47(1):38-44. PubMed ID: 26521710
[TBL] [Abstract][Full Text] [Related]
7. Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.
Meyer B; Stirzaker C; Ramkomuth S; Harvey K; Chan B; Lee CS; Karim R; Deng N; Avery-Kiejda KA; Scott RJ; Lakhani S; Fox S; Robbins E; Shin JS; Beith J; Gill A; Sioson L; Chan C; Krishnaswamy M; Cooper C; Warrier S; Mak C; Rasko JE; Bailey CG; Swarbrick A; Clark SJ; O'Toole S; Pidsley R
J Pathol; 2024 Apr; 262(4):480-494. PubMed ID: 38300122
[TBL] [Abstract][Full Text] [Related]
8. Phyllodes tumors of the breast: clinicopathological analysis of 106 cases from a single institution.
Efared B; Ebang GA; Tahiri L; Sidibé IS; Erregad F; Hammas N; Melhouf MA; Banani A; Chbani L; Fatemi HE
Breast Dis; 2018; 37(3):139-145. PubMed ID: 29332027
[TBL] [Abstract][Full Text] [Related]
9. Phyllodes tumor of the breast. A cytohistologic study of 80 cases.
Bhattarai S; Kapila K; Verma K
Acta Cytol; 2000; 44(5):790-6. PubMed ID: 11015981
[TBL] [Abstract][Full Text] [Related]
10. Radiopathological characteristics and outcomes of phyllodes tumor of the breast in Malaysian women.
Abdul Hamid S; Rahmat K; Ramli MT; Fadzli F; Jamaris S; See MH; Teoh KH; Taib NAM
Medicine (Baltimore); 2018 Aug; 97(31):e11412. PubMed ID: 30075507
[TBL] [Abstract][Full Text] [Related]
11. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.
Zhang Y; Kleer CG
Arch Pathol Lab Med; 2016 Jul; 140(7):665-71. PubMed ID: 27362571
[TBL] [Abstract][Full Text] [Related]
12. Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast.
Vidal M; Peg V; Galván P; Tres A; Cortés J; Ramón y Cajal S; Rubio IT; Prat A
Mol Oncol; 2015 Jun; 9(6):1081-90. PubMed ID: 25687451
[TBL] [Abstract][Full Text] [Related]
13. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic stromal histomorphology in fibroepithelial breast lesions: a fresh perspective.
Aiyer HM; Jain M; Thomas S; Logani KB
Indian J Pathol Microbiol; 2000 Jan; 43(1):5-12. PubMed ID: 12583412
[TBL] [Abstract][Full Text] [Related]
15. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
[TBL] [Abstract][Full Text] [Related]
16. [The important morphological parameters used to differentiate benign/malignant phyllodes tumors of the breast].
Küçük Ü; Pala EE; Bayol Ü; Erdoğan IG
Turk Patoloji Derg; 2012; 28(3):245-50. PubMed ID: 23011827
[TBL] [Abstract][Full Text] [Related]
17. Phyllodes tumours of the breast: retrospective analysis of a University Hospital's experience.
Toh YF; Cheah PL; Looi LM; Teoh KH; Tan PH
Malays J Pathol; 2016 Apr; 38(1):19-24. PubMed ID: 27126660
[TBL] [Abstract][Full Text] [Related]
18. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
19. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
[TBL] [Abstract][Full Text] [Related]
20. Phyllodes tumor with a benign heterologous osseous component: a diagnostic challenge.
Christensen LG; Di Caterino T; Talman ML
APMIS; 2019 Jun; 127(6):484-488. PubMed ID: 30901115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
